Clinical Trials on NTSR1 Expressing Solid Tumours
Total 5228 results
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Advaxis, Inc.CompletedHER2 Expressing Solid TumorsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2 Expressing or Mutated Advanced Malignant Solid TumorsChina
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Bristol-Myers SquibbCompletedHER2 or EGFR Expressing Advanced Solid MalignanciesSpain, France
-
Hassane M. Zarour, MDNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Fusion Pharmaceuticals Inc.RecruitingGastric Cancer | Colorectal Cancer | Ewing Sarcoma | Squamous Cell Carcinoma of Head and Neck | Pancreatic Ductal Adenocarcinoma (PDAC) | NTSR1 Expressing Solid Tumours | Neuroendocrine Differentiated (NED) Prostate CancerUnited States, Australia
-
Indiana University School of MedicineAstraZenecaTerminatedRefractory Germ Cell Tumors Expressing EGRFUnited States
-
Elpiscience Biopharma, Ltd.CompletedNeoplasms | Solid Tumors | Malignant TumorChina
-
Elpiscience Biopharma, Ltd.TerminatedNeoplasms | Solid Tumors | Malignant TumorChina
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
Georgetown UniversityImmune System Key LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsUnited States
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Breast Neoplasms | Adenocarcinomas | Metastatic Solid Tumors Characterized by HER2/Neu ExpressionUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsChina
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
Keystone Nano, IncNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedCarcinoma | Cancer | Solid Tumors | TumorUnited States
-
Fujian Cosunter Pharmaceutical Co. LtdUnknownSolid Tumor | C-Met Mutation-Related TumorsChina
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Esperance Pharmaceuticals IncCompletedAdvanced Solid Tumors | Solid TumorsUnited States
-
AstraZenecaParexelCompleted
-
AstraZenecaQuintiles, Inc.Completed
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRefractory Solid Tumors | Relapsed Solid TumorsChina
-
Genentech, Inc.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Korea, Republic of, United States, Brazil, Australia, Argentina, Spain, New Zealand, Poland
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.Completed
-
Debiopharm International SATerminatedSolid TumoursKorea, Republic of, United States, Taiwan, Spain, Singapore
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Incyte Biosciences Japan GKCompletedAdvanced Solid Tumors | Metastatic Solid TumorsJapan
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Bristol-Myers SquibbCompletedAdvanced Solid Tumors | Metastatic Solid TumorsKorea, Republic of, Canada, Australia
-
Aadi Bioscience, Inc.Active, not recruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmUnited States, Korea, Republic of, Puerto Rico
-
University of AlbertaWithdrawnLocally Advanced Solid Tumors | Metastatic Solid TumorsCanada
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
NeuPharma, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Dr David ZieglerEngeneic Pty LimitedTerminatedSolid Tumours | CNS TumoursAustralia
-
Hoffmann-La RocheRecruitingSolid TumoursBrazil, Germany, Taiwan, United Kingdom, France, Turkey, Slovenia, Canada, Ireland, India, Portugal, Thailand, South Africa, Serbia, Israel, Colombia, Spain, Greece, Mexico, Poland, Philippines, Argentina, Egypt, Chile, Estonia, Lebanon, Sl... and more
-
AstraZenecaCompletedSolid TumoursBelgium, Denmark, France, United Kingdom, Netherlands
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
LondonPharma Ltd.Unknown
-
AstraZenecaCompletedTo Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male VolunteersSolid TumoursUnited States
-
Zhuhai Beihai Biotech Co., LtdCompleted